Medicines · Antiparasitic

Praziquantel

Active Ingredient
Praziquantel
Medicine Type
Antiparasitic
Praziquantel

Observe and distinguish

Identification and context

Identity and formulation

Substance monograph for praziquantel. Products are not interchangeable: Prazi-Med is a 99.5% powder, while PraziPro is a solution with less than 7% praziquantel and its own vehicle; dosage and compatibility belong to each product.

Supported indications

Identified products list cestodes, monogeneans or other flatworms in specified ornamental fish. Confirm the parasite group and use only a product whose label covers the host, environment and indication.

Diagnostic prerequisites

Confirm host, diagnosis, net volume, water quality and exact formulation before use. Do not transfer directions between products.

Verify before intervening

Confirmation and decisions

Preparation and monitoring

United States: Prazi-Med (MIF 900-054) is indexed for specified ornamental uses and extra-label use is prohibited. PraziPro has its own composition. Verify status, excluded species and insert in the region of use.

Species and system compatibility

There is no universal compatibility: the FDA Prazi-Med label excludes Callichthyidae and Clariidae and requires caution with plants and invertebrates, while PraziPro makes different claims. Aerate, observe the host, do not directly discharge treated water, and do not transfer safety between formulations.

Interactions and contraindications

There is no universal compatibility: the FDA Prazi-Med label excludes Callichthyidae and Clariidae and requires caution with plants and invertebrates, while PraziPro makes different claims. Aerate, observe the host, do not directly discharge treated water, and do not transfer safety between formulations.

Proportionate actions

Management and monitoring

Adverse effects and failure

There is no universal compatibility: the FDA Prazi-Med label excludes Callichthyidae and Clariidae and requires caution with plants and invertebrates, while PraziPro makes different claims. Aerate, observe the host, do not directly discharge treated water, and do not transfer safety between formulations.

Operator safety

United States: Prazi-Med (MIF 900-054) is indexed for specified ornamental uses and extra-label use is prohibited. PraziPro has its own composition. Verify status, excluded species and insert in the region of use.

Regulatory status

Check authorisation, prescription status and conditions of use in the user’s jurisdiction; ornamental and food-producing animals are not interchangeable.

Evidence limitations

Manufacturer directions document only the stated formulation. Efficacy, safety and dosage do not automatically extend to the active substance or other products.

Active ingredient identity

Composition and chemical data

Praziquantel
FormulaC19H24N2O2
Molar Mass312.41 g/mol

Anthelmintic drug effective against flatworms, tapeworms, and flukes.

Safety Hazards (GHS)

  • Harmful to aquatic life with long lasting effects

Transparency

Information and documentation

Information

Active Ingredient
Praziquantel
Medicine Type
Antiparasitic

Documentation

  • Product Page

    FDA — Prazi-Med indexed product sheet (MIF 900-054)

    REGULATORYHIGH

    Applies only to the stated jurisdiction, product, formulation and revision date.

  • Instruction Manual

    Hikari — PraziPro product data sheet

    MANUFACTURER DOCUMENTATIONCONTEXT ONLY

    Manufacturer documentation is formulation-specific and is not independent evidence of efficacy.

  • Chemical Data

    PubChem — Praziquantel

    CHEMICAL DATABASECONTEXT ONLY

    Chemical identity data do not support aquarium dosing, efficacy or finished-product safety.

  • Chemical Data

    PubChem Chemical Data